Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
暂无分享,去创建一个
M. Stockler | V. Gebski | J. Zalcberg | V. Ganju | N. Tebbutt | G. van Hazel | T. Sourjina | M. Cummins | A. Strickland | D. Gibbs | G. V. Hazel | G. V. van Hazel | Niall C. Tebbutt | N. C. Tebbutt | J. Zalcberg | Martin R. Stockler | V. Gebski | Andrew Strickland | John R Zalcberg